Michelle Dawson posts

Post published on Twitter/X on 2 Aug 2013 03:56

Twitter/X DOI work crossref External link integrated into the post Autism terms

Structured cited links

1 cited resource

DOI work Fetched Post crossref

Neva M. Corrigan, Dennis W. W. Shaw, Annette M. Estes, Todd L. Richards, Jeff Munson, Seth D. Friedman, Geraldine Dawson, Alan A. Artru, et al. (2013). Atypical Developmental Patterns of Brain Chemistry in Children With Autism Spectrum Disorder. JAMA Psychiatry, 70(9), 964. American Medical Association (AMA).

Publication date
1 Sep 2013
Identifier
10.1001/jamapsychiatry.2013.1388
Authors
Neva M. Corrigan, Dennis W. W. Shaw, Annette M. Estes, Todd L. Richards, Jeff Munson, Seth D. Friedman, Geraldine Dawson, Alan A. Artru, Stephen R. Dager
Source
JAMA Psychiatry
Details
70(9), 964
Reference type
article
Publisher
American Medical Association (AMA)
Metadata source
crossref

Abstract

IMPORTANCE: Autism spectrum disorder (ASD) is a neurodevelopmental disorder with symptoms emerging during early childhood. The pathophysiology underlying the disorder remains incompletely understood. OBJECTIVE: To examine cross-sectional and longitudinal patterns of brain chemical concentrations in children with ASD or idiopathic developmental delay (DD) from 3 different age points, beginning early in the clinical course. DESIGN: Proton magnetic resonance spectroscopic imaging data were acquired longitudinally for children with ASD or DD, and primarily cross-sectionally for children with typical development (TD), at 3 to 4, 6 to 7, and 9 to 10 years of age. SETTING: Recruitment, diagnostic assessments, and magnetic resonance imaging were performed at the University of Washington in Seattle. PARTICIPANTS: Seventy-three children (45 with ASD, 14 with DD, and 14 with TD) at 3 to 4 years of age; 69 children (35 with ASD, 14 with DD, and 20 with TD) at 6 to 7 years of age; and 77 children (29 with ASD, 15 with DD, and 33 with TD) at 9 to 10 years of age. MAIN OUTCOMES AND MEASURES: Concentrations of N-acetylaspartate (NAA), choline (Cho), creatine (Cr), myo-inositol (mI), and glutamine plus glutamate (Glx) in cerebral gray matter (GM) and white matter (WM) at 3 to 4, 6 to 7, and 9 to 10 years of age, and calculation of rates of change of these chemicals between 3 and 10 years of age. RESULTS: At 3 to 4 years of age, the ASD group exhibited lower NAA, Cho, and Cr concentrations than did the TD group in both GM and WM, alterations that largely were not observed at 9 to 10 years of age. The DD group exhibited reduced GM and WM NAA concentrations at 3 to 4 years of age; GM NAA concentrations remained reduced at 9 to 10 years of age compared with the TD group. There were distinct differences between the ASD and DD groups in the rates of GM NAA, Cho, and Cr changes between 3 and 10 years of age. CONCLUSIONS AND RELEVANCE: The GM chemical changes between 3 and 10 years of age differentiated the children with ASD from those with DD. Most notably, a dynamic reversal of GM NAA reductions was observed in the children with ASD. By contrast, persistent GM NAA reductions in the children with DD suggest a different, more static, underlying developmental process.

Study authors in this cited reference